Psoriasis Completed Phase 1 / 2 Trials for Etanercept (DB00005)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00585650Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or FeetTreatment